>
>
Cell Cryopreservation Market - By Product Type (Cryoprotectant Agents, Equipment), Cell Type (Stem Cells, Oocytes & Embryotic Cells, Sperm Cells), Application (Drug Discovery & Development, Regenerative Medicine), End-use – Global Forecast, 2024 - 2032
Download Free PDF
![img](/assets/images/detail_form_pdf.webp)
Cell Cryopreservation Market
Get a free sample of this reportGet a free sample of this report Cell Cryopreservation Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2023
Companies covered: 10
Tables & Figures: 402
Countries covered: 22
Pages: 185
Download Free PDF
Cell Cryopreservation Market Size
Cell Cryopreservation Market size was valued at USD 10.4 billion in 2023 and is estimated to expand at 21.5% CAGR from 2024 to 2032. Cell cryopreservation is a technique used to preserve cells by freezing them at extremely low temperatures, typically in liquid nitrogen, to slow down their metabolic processes and prevent deterioration.
Globally, public biobanks are estimated to preserve more than 800,000 units of umbilical cord blood, whereas private cord blood banks may store as many as 4 million units. The growth of the cord stem cell banking is propelled by various factors, including the rising acceptance of stem cell therapeutics, increasing R&D in the field, etc. Additionally, the market is driven by the emergence of new applications for stem cells in disease treatment, augmented investment in the management of chronic diseases, heightened awareness surrounding stem cell therapeutics, and an upswing in mergers and acquisitions involving major industry players.
Furthermore, ongoing advancements in biopreservation, such as improved cryoprotectants and freezing techniques, contribute to the market growth by enhancing the efficiency and viability of preserved cells. Additionally, growing investments from both public and private sectors in the life sciences and healthcare sectors contribute to the expansion of cell cryopreservation technologies and services.
Cell Cryopreservation Market Trends
The cell cryopreservation field is witnessing a notable trend towards the integration of automation in its processes. This advancement is contributing to more precise and reproducible results. Automated systems are playing a pivotal role in streamlining workflows, mitigating human error, and enhancing overall efficiency, particularly in the realms of cell banking and storage.
Cell Cryopreservation Market Analysis
The market by product type is categorized into cryoprotectant agents and equipment. The equipment into garnered USD 7.5 billion revenue size in the year 2023. The equipment segment is further segmented freezers, incubators, liquid nitrogen supply tanks and cryopreservation consumables. Concurrently, there is a notable trend towards automation in cryopreservation equipment.
Based on cell type, the cell cryopreservation market unfolds its segmentation, such as stem cells, oocytes and embryotic cells, sperm cells, hepatocytes, and other cell types. The stem cells segment garnered USD 4 billion revenue size in the year 2023. Moreover, the therapeutic potential of stem cells is broad and continues to expand, contributing significantly to the growth of the stem cells segment.
Based on application, the cell cryopreservation market is segmented into drug discovery and development, regenerative medicine, organ transplantation, clinical research, other applications. The drug discovery and development segment garnered USD 2.6 billion revenue size in the year 2023.
Based on end-use, the cell cryopreservation market unfolds its segmentation, encompassing the domains of hospitals and clinics, biotechnology and pharmaceutical companies, research and academic institutes, contract research organizations (CROs), which is estimated to account for USD 56.7 billion in 2022. The biotechnology and pharmaceutical companies segment garnered USD 3.4 billion revenue size in the year 2023.
U.S. cell cryopreservation market accounted for USD 4.3 billion revenue size in 2023 and is predicted to witness substantial market growth over the analysis timeline.
Cell Cryopreservation Market Share
The cell cryopreservation industry is consolidated, with key players including Thermo Fisher Scientific Inc., Sartorius AG, GE Healthcare, Danaher Corporation, and others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market shares.
For instance, in July 2023, Sartorius opened a manufacturing facility for cell culture media in Puerto Rico. These media played a crucial role in producing therapeutic proteins and various modalities. This development enhanced Sartorius manufacturing capacity along with extensive portfolio, particularly in the North & South America region.
Cell Cryopreservation Market Companies
Some of the eminent market participants operating in the cell cryopreservation industry include:
Cell Cryopreservation Industry News:
Cell cryopreservation market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product Type, 2018 – 2032 (USD Million)
By Cell Type, 2018 – 2032 (USD Million)
By Application, 2018 – 2032 (USD Million)
By End-use, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries: